- Tous > Medicine Information and Evidence for Policy > Medicines Policy
- Tous > Medicine Information and Evidence for Policy > Monitoring and Evaluation
- Tous > Medicine Access and Rational Use > Good Governance for Medicines
- Tous > Medicine Access and Rational Use > Pricing
- Tous > Medicine Access and Rational Use > Rational Use
- Tous > Medicine Access and Rational Use > Selection
- Tous > Medicine Access and Rational Use > Supply Management
- Tous > Quality and Safety: Medicines > Quality Assurance
- Tous > Quality and Safety: Medicines > Regulatory Support
- Tous > Quality and Safety: Medicines > Safety and Efficacy
- Mots-clés > access to pharmaceutical services
- Mots-clés > annual report
- Mots-clés > availability, affordability, and quality of pharmaceutical products
- Mots-clés > Essential Medicines and Health Products
- Mots-clés > global medicines activities
- Mots-clés > key achievements
- Mots-clés > medicines strategy
- Mots-clés > official development assistance (ODA)
- Mots-clés > progress report
- Mots-clés > Strengthening Pharmaceutical Systems (SPS)
(2018; 70 pages)
Systems for Improved Access to Pharmaceuticals and Services. 2018. Toward Building Resilient Pharmaceutical Systems: SIAPS Final Report. Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health.
SIAPS final report showcases achievements across 46 countries. Interventions are described by intermediate results and health areas and demonstrate how SIAPS successfully worked with a range of stakeholders, including Ministries of Health, to bolster pharmaceutical systems and address country-specific needs.
Strengthening efforts demand a commensurate legal and policy foundation coupled with good governance practices to minimize and mitigate opportunities for inefficiencies and corruption. By doing so, pharmaceutical systems are well positioned to respond to health challenges such as controlling the costs of medicines and services, which cannot be ignored as countries move along the path toward universal health coverage (UHC).
From 2011 to 2018, the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program worked with local counterparts and partners in 46 countries to comprehensively strengthen pharmaceutical systems by addressing five interrelated health systems functions—governance, human resources, information, financing, and service delivery—to ultimately address disease-specific and country needs. The SIAPS pharmaceutical systems strengthening (PSS) approach ensured equitable access to and appropriate use of effective pharmaceutical technologies and medicines for diagnosis and treatment of major public health areas, including malaria; HIV/AIDS; family planning; maternal, newborn, and child health (MNCH); tuberculosis (TB); neglected tropical diseases (NT Ds); and, more recently, Ebola. By helping countries meet disease-specific targets, the SIAPS implementation strategy strengthened pharmaceutical systems to provide a wider range of medicines and pharmaceutical products, ultimately producing improved health outcomes.